Literature DB >> 24343245

[Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration : Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices].

B Bertram1, C Gante, R-D Hilgers.   

Abstract

BACKGROUND: The importance of the four most commonly occurring vision-threatening diseases, age-related macular degeneration (AMD), glaucoma, diabetic retinopathy and cataract in ophthalmological practices has changed due to demographic developments, medical progress and transference of inpatient treatment to the outpatient area of private practice.
METHODS: In the fourth quarter year of 2010 a survey of 15,125 patients (approximately 10%) from 96 private ophthalmology practices (mean 149 patients per ophthalmologist, range 45-376) was carried out. The results for the four most commonly occurring vision-threatening diseases were compared with the result from a previous survey carried out for the fourth quarter year of 1997.
RESULTS: Compared to 1997 there was an increase in the age-adjusted proportion of examinations in 2010 for cataracts by 29 %, for glaucoma by 21 %, for diabetic retinopathy by 39 % and for vitreoretinal diseases by 19 %. The number of AMD examinations in the age group over 70 years old showed a particularly high increase.
CONCLUSIONS: The number of patients examined for the four most commonly occurring vision-threatening diseases increased from 1997 to 2010 not only in absolute numbers but also in relation to age. In the future financial and personnel resources must be made available for the early and guidelines-conform detection, diagnostics and therapy by ophthalmologists.

Entities:  

Mesh:

Year:  2014        PMID: 24343245     DOI: 10.1007/s00347-013-2966-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  8 in total

1.  Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010.

Authors:  Sara Brandi Bloch; Michael Larsen; Inger Christine Munch
Journal:  Am J Ophthalmol       Date:  2012-02       Impact factor: 5.258

2.  Blindness and low vision in Germany 1993-2009.

Authors:  Christian Wolfram; Norbert Pfeiffer
Journal:  Ophthalmic Epidemiol       Date:  2012-02       Impact factor: 1.648

3.  [Anti-VEGF therapy in neovascular age-related macular degeneration: therapeutic strategies].

Authors: 
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

4.  [Age, sex and diagnostic distribution of patients in ophthalmological medical practice in Germany].

Authors:  B Bertram; C Gante; R-D Hilgers
Journal:  Dtsch Med Wochenschr       Date:  2012-08-08       Impact factor: 0.628

5.  Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.

Authors:  Heiner Claessen; Jutta Genz; Bernd Bertram; Christoph Trautner; Guido Giani; Iris Zöllner; Andrea Icks
Journal:  Eur J Epidemiol       Date:  2012-06-19       Impact factor: 8.082

6.  Reduced incidence of blindness in relation to diabetes mellitus in southern Germany?

Authors:  J Genz; M Scheer; C Trautner; I Zöllner; G Giani; A Icks
Journal:  Diabet Med       Date:  2010-10       Impact factor: 4.359

7.  [Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002-2004].

Authors:  M Blum; C Kloos; N Müller; A Mandecka; R Berner; B Bertram; U A Müller
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

8.  Blindness and visual impairment in Germany: a slight fall in prevalence.

Authors:  Robert P Finger; Bernd Bertram; Christian Wolfram; Frank G Holz
Journal:  Dtsch Arztebl Int       Date:  2012-07-09       Impact factor: 5.594

  8 in total
  5 in total

1.  [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

Authors:  F Ziemssen; K Lemmen; B Bertram; H P Hammes; H Agostini
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

2.  [Who visits an ophthalmologist and how often? Results of the German nationwide adult health survey (DEGS1)].

Authors:  A K Schuster; C Wolfram; B Bertram; N Pfeiffer
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

Review 3.  [Macroeconomic costs of eye diseases].

Authors:  C Hirneiß; A Kampik; A S Neubauer
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

4.  [Health services for patients with neovascular age-related macular degeneration in Germany].

Authors:  R P Finger; F G Holz
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

5.  Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future.

Authors:  Johanna M Colijn; Gabriëlle H S Buitendijk; Elena Prokofyeva; Dalila Alves; Maria L Cachulo; Anthony P Khawaja; Audrey Cougnard-Gregoire; Bénédicte M J Merle; Christina Korb; Maja G Erke; Alain Bron; Eleftherios Anastasopoulos; Magda A Meester-Smoor; Tatiana Segato; Stefano Piermarocchi; Paulus T V M de Jong; Johannes R Vingerling; Fotis Topouzis; Catherine Creuzot-Garcher; Geir Bertelsen; Norbert Pfeiffer; Astrid E Fletcher; Paul J Foster; Rufino Silva; Jean-François Korobelnik; Cécile Delcourt; Caroline C W Klaver
Journal:  Ophthalmology       Date:  2017-07-14       Impact factor: 12.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.